Connect with us

World

Personal Injury Lawyer Richard Console Helping Those Impacted By Popular Diabetes Drug Metformin

mm

Published

on

Doctors have prescribed Metformin to more than 120 million patients worldwide to manage diabetes and other health conditions. Although the FDA has only approved Metformin for the treatment of type-2 diabetes, the drug is widely used off-label to treat many other conditions — including prediabetes, gestational diabetes, polycystic ovary syndrome (PCOS), fertility problems and more.

In June 2020, a recall of the drug was announced by drugmaker Apotex, after finding certain batches containing possible high levels of NDMA, a known animal carcinogen which is also believed to cause cancer in humans. Due to Metformin often being prescribed for off-label use, this means that even a greater number of patients have suffered harm from it. 

Metformin Recall

In May 2020, the FDA identified five pharmaceutical companies that produced batches of Metformin that, according to the agency’s laboratory tests, contained unacceptably high levels of NDMA. The contaminated lots of Metformin that have been recalled are only the extended-release tablets.

As of early June 2020, four of the five pharmaceutical companies that produced contaminated batches of Metformin have initiated recalls of 28 products:

  1. Apotex, which recalled all lots of its metformin products with the NDC (National Drug Code) identification number 60505-0260-1
  2. Actavis Generics (part of Teva Pharmaceuticals), which recalled 14 items with various NDC and lot numbers
  3. Amneal Pharmaceuticals, which recalled all lots of 12 metformin products with various NDC numbers
  4. Time-Cap Labs, Inc. (part of Marksans Pharma), which recalled just 1 lot of metformin (lot number XP9004)

Metformin, NDMA and Cancer

While NDMA is dangerous and a known animal carcinogen and probable human carcinogen, it is fairly common and can be found in everything from air, soil, water and consumer products like cured meat, tobacco and shampoo, according to Everyday Health. Because exposure to very small amounts of NDMA is unavoidable, the FDA set a maximum “reasonably safe” daily intake of 96 nanograms, the equivalent to one billionth of a gram.

Consuming more than the maximum daily amount could raise your risk for cancer. The FDA released a public statement advising the public, “Although there are no reports of NDMA causing cancer in humans, it is reasonable to expect that exposure to NDMA by eating, drinking or breathing could cause cancer in humans.”

According to online pharmacy Valisure, who conducted independent laboratory testing of Metformin, several of the affected batches of the drug contained more than ten times that amount. The batches that performed the worst testing for NDMA had 16 times the recommended amount.

“Imagine ingesting 16 times what’s recommended as the maximum exposure — on top of whatever environmental or dietary exposures you might have —every single day, for years, decades, or even a lifetime,” stated personal injury attorney, Richard Console

The cancer-causing impact of NDMA is believed to be cumulative. “It’s easy to see how a patient exposed to the carcinogen through their diabetes medication could continue to unknowingly stack their cancer risk higher as the year’s pass,” empathizes Console.

Over the years, a myriad of laboratory research on animals and human observation studies those who have been exposed to NDMA. Findings have shown that the chemical can cause or contribute to developing several different forms of cancers. Possible overexposure to the powerful carcinogen has been linked to more than a dozen types of cancer, including the following:

  • Prostate Cancer
  • Lower Esophageal Cancer
  • Non-Hodgkin’s Lymphoma
  • Leukemia
  • Multiple Myeloma
  • Colon Cancer
  • Stomach Cancer
  • Intestinal Cancer
  • Pancreatic Cancer

What You Should Do

First, call your doctor if you have recently been taking Metformin or if you were prescribed it in the past. Do not stop taking the drug without first speaking to a medical professional, as it could cause side effects. The sooner you reach out to your physician to discuss your risks and options, the better.

Once you have spoken to your doctor, contact an attorney. Because cancer often presents itself without an obvious origin, determining whether it’s likely that NDMA caused you to develop cancer, it may be best to reach out to a Metformin injury lawsuit attorney right away. When working to determine a substantial case, they will explore questions like:

  • How long and at what dosage have you been taking Metformin?
  • When were you diagnosed with cancer?
  • In general, is the type of cancer you developed common or rare? What about for patients in your age group, specifically?
  • What risk factors did you already have for cancer you developed?
  • What stage was or is your cancer? Has it seemed to progress more quickly than expected?
  • Has a doctor suggested there may be a link between the medication you took and your cancer? What might a medical expert think?

Additionally, for those that used Metformin prior to developing cancer and developed a rare cancer for which they didn’t have risk factors, there’s a strong chance that NDMA from diabetes medication could be to blame. Those who believe they may have developed cancer after taking Metformin may be eligible for a mass tort claim, which may make getting the compensation you deserve easier.

“When you are taking a medication that is supposed to help you, it’s hard to accept that it could have caused more harm than good,” says Console. “A lawsuit cannot give you back what you have lost, but personal injury attorneys are there to be your advocate and get the justice and compensation to minimize the overwhelming financial burden of a cancer battle.”

Richard P. Console, Jr. is the founder of Console and Associates, PC. He opened his law firm to serve one vital purpose: to help the victims of accidents and injuries at the time when they need help the most. Mr. Console is licensed to practice law in Pennsylvania, New Jersey, and New York. Since 1994, he has represented over 7,000 clients and has achieved a record of success getting clients every dollar of compensation they deserve.

If you or anyone you know has developed cancer following regular use of Metformin, please speak with a Metformin lawsuit attorney right away.

Jenny is one of the oldest contributors of Bigtime Daily with a unique perspective of the world events. She aims to empower the readers with delivery of apt factual analysis of various news pieces from around the World.

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

World

Criminal probe focussed on Mehtas shipping business

mm

Published

on

From Monitoring Desk

DUBAI: An Asian family linked with the shipping business is facing criminal investigation in several jurisdictions including in Dubai and Far East where the family’s companies are under active investigation now, according to the authorities in three countries.

Sanjay and Gaurav Mehta, through their companies Best Oasis Ltd in Dubai and Priya Blue Industries in Gujarat, are facing investigations over money-laundering suspicions and suspected links to the Russian oil sector, sanctioned by the western countries, sources shared.

Sanjay and Gaurav Mehta, through their companies Best Oasis Ltd in Dubai and Priya Blue Industries in Gujarat have projected an image of environmental responsibility in ship recycling. They have tout certifications, attend global summits, and positioned themselves as ESG-compliant but their business practices have come under intense probe now. Their operations reportedly involve dismantling high-risk ships, using cash transactions, and leveraging political connections to avoid accountability, a source shared looking into the companies’ affairs. The investigation is being conducted in Dubai and the Far East.

The investigators are looking at the Mehtas operations dating back to 2006 when they came to attention of the law enforcement for the first time. Priya Blue dismantled the “Blue Lady” in 2006, a vessel containing over 1,200 tons of asbestos and radioactive waste, despite protests and objections from Greenpeace. Later, the “Exxon Valdez,” notorious for a major oil spill, was renamed “Oriental Nicety” and dismantled by the Mehtas in Gujarat, drawing international attention. In recent years, their transactions have become less conspicuous but reportedly more hazardous.

In 2025, Best Oasis allegedly acquired and dismantled at least four vessels linked to sanctioned entities, including Iranian and Houthi-controlled networks. These weren’t obscure ships; they were designated under U.S. terrorism sanctions for their involvement in oil smuggling and arms transport. According to investigators, here are the details of the sanctioned ships dismantled by Best Oasis in 2025: IMO: 9155808, Name: NOLAN (SOLAN), Sanction: SDN (SDGT), Beaching: 31 Jan 2025, Plot 16; IMO: 9221657, Name: BLUEFINS, Sanction: SDN (SDGT); Beaching: 26 Feb 2025, Plot 16; IMO: 9105085, Name: CONTRACT II, Sanction: SDN risk, Beaching: Arrived mid-2025, Plot 27; IMO: 9209300, Name: GAMA II, Sanction: SDN (SDGT); and Beaching: Pending/Planned, Plot 34

All four vessels were reportedly dismantled in Alang on plots leased by proxy firms connected to the Mehtas. These short-term leases, approved on a ship-by-ship basis by the Gujarat Maritime Board, reportedly make regulatory oversight nearly impossible. Once dismantling is complete, plot registrations often lapse, leaving no long-term record, according to documents shared by the investigators in Dubai.

Rahul Mistry, a shipping compliance researcher, noted this as a growing pattern: “This is a pattern we’ve seen more frequently in the last two years   sanctioned hulls arriving under the radar, processed fast, with no digital trace.”

Payments for these vessels reportedly bypassed normal financial channels. According to sources familiar with the deals, transactions were settled in cash, either on-site or through offshore handlers. One source described entire ship values being paid in foreign currency bundles, avoiding Indian and Dubai banking disclosures, said one of the investigators familiar with the matter.

A retired port official Mr. Akin Yadav, familiar with Alang  and Gujarat Maritime Board approvals stated that short-term leases are routinely used to avoid scrutiny, adding, “It was never meant to be a permanent workaround. But it’s become one.”

Political connections also reportedly play a role. Union Minister Mansukh Mandaviya and Gujarat State Minister Jitu Vaghani have been linked to approvals granted for Best Oasis and its proxies. While there’s no direct evidence of personal gain, sources allege that both men used their influence to expedite approvals, slow down inquiries, and shield the companies from enforcement.

Despite these activities in India, Best Oasis is expanding under new branding. A recent joint venture in Japan with Hiroshi Abe is being marketed as a clean, regionally responsible recycling partner for Japanese shipowners.

Mariko Fujita, a Tokyo-based maritime consultant, observed, “They’re presenting themselves as a new entity with no reference to past controversies. But none of the underlying ownership or structure has changed.”

In Alang, the situation reportedly remains much the same. Plot numbers are reassigned, cash continues to circulate and the same network of breakers and handlers is reportedly involved. Individuals like Jayant Vanani (also known as Budhabhai Patel) and Ramesh Mendapara are frequently named in connection with specific beachings, including “Contract II” and “GAMA II.” Both have been previously linked to other shadow transactions involving distressed or sanctioned tonnage.

Several yards allegedly connected to Best Oasis, including Shantamani Ship Breakers and Sai Baba Ship Breakers, reportedly operate with minimal inspection, despite numerous reports of irregularities in worker safety, hazardous waste disposal, and compliance with Indian scrapping codes.

This system, according to multiple sources, appears to be intentionally designed to operate in plain sight with just enough paperwork to pass basic scrutiny but not enough to trigger meaningful enforcement. There is no indication that regulatory bodies including customs, port health officers, or environmental oversight panels have conducted full inspections of any of the sanctioned vessels listed. Most were reportedly cleared and dismantled within days of arrival.

Rahul Mistry said: “This isn’t merely a loophole; it’s reportedly a business model. Best Oasis and Priya Blue are allegedly running a high-volume, low-visibility operation that filters sanctioned, end-of-life ships through legal instruments to appear legitimate on paper. This reportedly involves routing untaxed funds and shielded actors through a well-connected political and industrial network. As global scrutiny of ESG practices intensifies, many of these activities are allegedly being whitewashed through new partnerships and branding, but the underlying mechanisms reportedly remain unchanged.”

Continue Reading

Trending